A detailed history of Fmr LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,950,279 shares of IPSC stock, worth $4.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,950,279
Previous 3,371,228 12.49%
Holding current value
$4.87 Million
Previous $14.1 Million 46.61%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.46 - $4.05 $1.04 Million - $1.7 Million
-420,949 Reduced 12.49%
2,950,279 $7.52 Million
Q1 2024

May 13, 2024

SELL
$3.19 - $5.32 $769,820 - $1.28 Million
-241,323 Reduced 6.68%
3,371,228 $14.1 Million
Q4 2023

Feb 13, 2024

SELL
$1.28 - $3.32 $1.17 Million - $3.03 Million
-912,078 Reduced 20.16%
3,612,551 $12 Million
Q3 2023

Nov 13, 2023

SELL
$2.0 - $3.23 $1.29 Million - $2.08 Million
-643,866 Reduced 12.46%
4,524,629 $9.05 Million
Q2 2023

Aug 11, 2023

SELL
$2.91 - $3.53 $507,760 - $615,942
-174,488 Reduced 3.27%
5,168,495 $16.3 Million
Q1 2023

May 11, 2023

SELL
$3.4 - $5.11 $5.96 Million - $8.96 Million
-1,753,428 Reduced 24.71%
5,342,983 $18.5 Million
Q4 2022

Feb 13, 2023

SELL
$4.84 - $11.58 $638,347 - $1.53 Million
-131,890 Reduced 1.82%
7,096,411 $36.4 Million
Q3 2022

Nov 10, 2022

SELL
$8.57 - $13.1 $2.98 Million - $4.56 Million
-348,084 Reduced 4.59%
7,228,301 $71.5 Million
Q2 2022

Aug 12, 2022

SELL
$7.96 - $12.43 $5.2 Million - $8.12 Million
-652,906 Reduced 7.93%
7,576,385 $63.6 Million
Q1 2022

May 13, 2022

BUY
$11.62 - $15.92 $384,482 - $526,760
33,088 Added 0.4%
8,229,291 $104 Million
Q4 2021

Feb 14, 2022

BUY
$13.93 - $23.62 $496,172 - $841,320
35,619 Added 0.44%
8,196,203 $130 Million
Q3 2021

Nov 15, 2021

BUY
$20.8 - $31.93 $66.6 Million - $102 Million
3,201,173 Added 64.55%
8,160,584 $205 Million
Q2 2021

Aug 13, 2021

BUY
$22.45 - $29.34 $111 Million - $146 Million
4,959,411 New
4,959,411 $146 Million

Others Institutions Holding IPSC

About Century Therapeutics, Inc.


  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $97.2M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.